KP Tissue (TSE:KPT) Price Target Raised to C$14.00

KP Tissue (TSE:KPT) had its price target increased by TD from C$12.00 to C$14.00 in a research report released on Tuesday,BayStreet.CA reports. The brokerage currently has a hold rating on the stock.

Separately, Desjardins lifted their price objective on KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a research report on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, KP Tissue has an average rating of “Hold” and an average price target of C$12.12.

KP Tissue Trading Up 0.9%

KPT stock opened at C$13.16 on Tuesday. The firm has a 50-day moving average of C$12.66 and a two-hundred day moving average of C$11.41. KP Tissue has a 12 month low of C$8.86 and a 12 month high of C$13.78. The company has a market cap of C$131.97 million, a price-to-earnings ratio of 14.62, a PEG ratio of -0.88 and a beta of 0.53.

KP Tissue (TSE:KPT) last issued its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. As a group, equities analysts forecast that KP Tissue will post 0.4398964 earnings per share for the current year.

KP Tissue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 15th were issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 6.4%. The ex-dividend date was Tuesday, June 30th. KP Tissue’s payout ratio is 80.00%.

Insider Buying and Selling

In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the transaction, the director owned 15,712 shares of the company’s stock, valued at C$208,969.60. This trade represents a 18.93% decrease in their ownership of the stock. Insiders have sold a total of 6,668 shares of company stock valued at $87,644 over the last 90 days. Corporate insiders own 0.14% of the company’s stock.

KP Tissue Company Profile

KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.